SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-067135
Filing Date
2018-11-09
Accepted
2018-11-09 07:05:35
Documents
3
Period of Report
2018-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-39909_18k.htm 8-K 24422
2 EX-99.1 a18-39909_1ex99d1.htm EX-99.1 82341
3 GRAPHIC g399091mmi001.jpg GRAPHIC 2594
  Complete submission text file 0001104659-18-067135.txt   111580
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 181171316
SIC: 2834 Pharmaceutical Preparations